Disclaimer:
Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), Zepbound® (tirzepatide), Saxenda® (liraglutide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Wegovy®, Saxenda®, and Zepbound® are FDA-approved for weight loss. Ozempic®, Saxenda®, and Wegovy® are the registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Twentyeight Health is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
‍
Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate for you.
‍
Important safety and prescribing information: Â
‍
Side effects:
Many people experience no side effects while taking semaglutide. Some of the most common or potential side effects include:
‍
Nausea
Constipation
Vomiting
Diarrhea
Abdominal pain
Headache
Gastroesophageal reflux disease/Indigestion (Heart burn)
Injection site reactions
Dizziness
Back pain
Increased lipase or amylase (found during a blood test for pancreatic concerns)
Altered taste
Nasopharyngitis (common cold)
Passing gas
Bloating
Belching
Gastroenteritis (inflammation of the stomach/intestines)
Decreased appetite
Fatigue
Low blood sugar (hypoglycemia) in those with type 2 diabetes
Upset stomach
‍
These symptoms often subside as your body adjusts to the medications. Please notify your provider if side effects persist. For a complete list of side effects, review the medication packaging inserts.
‍
Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:
‍
Drug interactions:
As with other medications, semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with other drugs that may lower blood sugar, such as insulin or insulin secretagogues such as sulfonylureas. Semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (i.e., warfarin) should be monitored closely while on semaglutide. Talk to your health care provider if you are taking levothyroxine before taking semaglutide.
‍
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
‍
To report suspected adverse reactions to any of these prescription products, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
‍
In case of emergencies, please call 911 or go to the nearest emergency room.
‍
Contraindications:Â
Do not use Wegovy if you have any of the below conditions. If anything changes and you develop one of these conditions, please stop taking this medication and contact your provider immediately. This list may not be all inclusive, reach out to your provider with any questions.Â
‍
‍
Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
‍
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.Â
‍
‍
Treatment Failure
This treatment is not guaranteed to be effective. It may not work or may only partially resolve the condition for which you are seeking treatment. In some cases, you may need to seek alternative treatment. If the treatment is not working, or if you are experiencing new or worsening symptoms, reach out to your Twentyeight Health provider for support. If it is an emergency, call 911 or seek immediate medical help in person.Â
‍